122 results
8-K
EX-10.1
THER
Theralink Technologies, Inc.
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
Materials, which at all times will be in form and substance reasonably acceptable to the Placement Agent and the Company and their respective counsels … and desirable to be set forth therein. “Disclosure Materials” as used in this Agreement means that certain Securities Purchase Agreement pursuant to which
8-K
EX-10.1
THER
Theralink Technologies, Inc.
14 Sep 11
PediatRx enters U.S. co-promotion agreement for AQUORALTM
12:00am
, contraindications, side effects, warnings and other relevant characteristics of the Product and using, as necessary or desirable, Promotional Materials … Materials supplied by Company in accordance with this Agreement provided such Promotional Materials meet FDA and other regulatory and compliance standards
8-K
gmci7w jjmfuf5
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
D
bv4hmdj71a4zzjif
9 Jul 10
$175K in equity, sold $175K, 2 investors
12:00am
D
udfepta9nmu5dqsg
29 May 19
$184.95K in debt / securities to be acquired, sold $184.95K, 36 investors
1:08pm
8-K
EX-10.10
e3m6akcx9t7 79o169pr
28 Jul 10
Entry into a Material Definitive Agreement
12:00am
D
hodrbb4md4px78
15 Jun 10
$10K in equity, sold $10K, 1 investor
12:00am
8-K
EX-10.1
7dpq9 w4tnszja62g
8 Dec 22
Theralink® Technologies Appoints Seasoned Commercial Leader, Faith Zaslavsky, as President & Chief
7:23pm
D
t8oswa
9 Oct 18
$1.23M in debt / securities to be acquired, sold $1.23M, 4 investors
4:13pm
D
v6hrena8sp
12 Feb 21
$4M in equity, sold $400K, 4 investors
2:57pm
D
oz01quv1wjhlc7
14 Dec 22
$3.40 mm in debt / options, 12 investors
4:54pm
8-K
EX-10.4
5tchtz2bpae6u mqj
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm